A compact Toronto-based intellectual property law firm, Belmore Neidrauer is a respected name in the IP market that is primarily known for its expertise in pharmaceutical litigation. The team offers significant experience and skill in a variety of complex patent disputes.
A team led by Peter Wilcox and Marian Wolanski represented Janssen in patent infringement action against Teva, involving the former's schizophrenia treatment drug Paliperidone.
Peter Wilcox is a prominent and highly regarded patent disputes lawyer who has represented numerous industry leaders in the pharmaceutical and broader life sciences sector in complex patent litigation. "Peter Wilcox vigorously advances his client's interests and has a great courtroom presence."